|
|||||
|
|
The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer |
|
| Authors: | Weijing Cai PhD Jiayu Li PhD Fei Zhou MD Ningning Cheng PhD Ruixin Ren MD Chao Zhao Xuefei Li PhD Shengxiang Ren MD Caicun Zhou MD PhD Fred R. Hirsch MD PhD |
| Affiliation: | 1. Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China;2. Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado;3. Department of Pathology, University of Colorado Cancer Center, Aurora, Colorado |
| Abstract: | |
| Keywords: | tyrosine kinase inhibitors non– small cell lung cancer B‐cell chronic lymphocytic leukemia/lymphoma (Bcl‐2)‐like 11 Bim epidermal growth factor receptor EGFR polymorphism |